Search Results - "GIORDANO ATTIANESE, Greta Maria Paola"
-
1
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Published in Immunological reviews (01-11-2023)“…Adoptive T-cell transfer (ACT) therapies, including of tumor infiltrating lymphocytes (TILs) and T cells gene-modified to express either a T cell receptor…”
Get full text
Journal Article -
2
Hemicentin 1 influences podocyte dynamic changes in glomerular diseases
Published in American journal of physiology. Renal physiology (01-06-2018)“…Different complex mechanisms control the morphology of podocyte foot processes and their interactions with the underlying basement membrane. Injuries to this…”
Get more information
Journal Article -
3
Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors
Published in Haematologica (Roma) (01-12-2010)“…Cytokine-induced killer cells are ex vivo-expanded cells with potent antitumor activity. The infusion of cytokine-induced killer cells in patients with acute…”
Get full text
Journal Article -
4
Magnesium sensing via LFA-1 regulates CD8+ T cell effector function
Published in Cell (17-02-2022)“…The relevance of extracellular magnesium in cellular immunity remains largely unknown. Here, we show that the co-stimulatory cell-surface molecule LFA-1…”
Get full text
Journal Article -
5
CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
Published in Frontiers in immunology (05-08-2022)“…Chimeric antigen receptor (CAR) T cells have emerged as a powerful immunotherapeutic tool against certain hematological malignancies but a significant…”
Get full text
Journal Article -
6
Delayed Hair Follicle Morphogenesis and Hair Follicle Dystrophy in a Lipoatrophy Mouse Model of Pparg Total Deletion
Published in Journal of investigative dermatology (01-03-2018)“…PPARγ regulates multiple aspects of skin physiology, including sebocyte differentiation, keratinocyte proliferation, epithelial stem cell survival, adipocyte…”
Get full text
Journal Article -
7
Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies
Published in Haematologica (Roma) (01-03-2007)“…"Centro di Ricerca Matilde Tettamanti", Department of Paediatrics, University of Milano-Bicocca, San Gerardo Hospital, Monza, Milan, Italy. Correspondence:…”
Get full text
Journal Article -
8
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia
Published in Leukemia & lymphoma (07-06-2022)“…Chimeric antigen receptors (CAR)-modified T cells are an emerging therapeutic tool for chronic lymphocytic leukemia (CLL). However, in patients with CLL,…”
Get full text
Journal Article -
9
Enforcing GLUT3 expression in CD8 + T cells improves fitness and tumor control by promoting glucose uptake and energy storage
Published in Frontiers in immunology (20-09-2022)“…Despite the tremendous success of adoptive T-cell therapies (ACT) in fighting certain hematologic malignancies, not all patients respond, a proportion…”
Get full text
Journal Article -
10
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor
Published in Blood (05-05-2011)“…Chronic lymphocytic leukemia (CLL) is characterized by an accumulation of mature CD19+CD5+CD20dim B lymphocytes that typically express the B-cell activation…”
Get full text
Journal Article -
11
A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism
Published in Biosensors & bioelectronics (15-01-2023)“…Nicotinamide riboside (NR) is a form of vitamin B3 and is one of the most studied compounds for the restoration of cellular NAD+ levels demonstrating clinical…”
Get full text
Journal Article -
12
Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs
Published in Proceedings of the National Academy of Sciences - PNAS (29-10-2024)“…The ability to remotely control the activity of chimeric antigen receptors (CARs) with small molecules can improve the safety and efficacy of gene-modified T…”
Get full text
Journal Article -
13
A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor
Published in Nature biomedical engineering (01-09-2023)“…Vectors that facilitate the engineering of T cells that can better harness endogenous immunity and overcome suppressive barriers in the tumour microenvironment…”
Get full text
Journal Article -
14
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells
Published in Blood (15-11-2013)“…Gene-manipulation of effector T cells with CARs has recently turned into a powerful tool to redirect antigen specificity for adoptive immunotherapy of tumors…”
Get full text
Journal Article -
15
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor
Published in Blood (16-11-2012)“…Abstract 3010 Current therapeutic regimens for Acute Myeloid Leukemia (AML) are still associated with high rates of relapse. In the last years, great interest…”
Get full text
Journal Article -
16
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo
Published in Blood (15-11-2013)“…Chronic Lymphocytic Leukemia (CLL) is a chronic lymphoid malignancy characterized by immune suppression that is responsible for an increase in infection…”
Get full text
Journal Article -
17
A New Chimeric Antigen Receptor (CAR) Targeting the CD23 Antigen Expressed by Chronic Lymphocytic Leukemia (B-CLL) Cells
Published in Blood (19-11-2010)“…Abstract 2446 B-Chronic lymphocytic leukemia (B-CLL) is characterized by a progressive accumulation of B-lymphocytes expressing CD19, CD20dim and aberrantly…”
Get full text
Journal Article -
18
Generation of a New Chimeric Antigen Receptor (CAR) to Target CD23 Expressed on Chronic Lymphocytic Leukemia (B-CLL) Cells
Published in Blood (16-11-2008)“…B-Chronic lymphocytic leukemia (B-CLL) is characterized by a progressive accumulation of mature B-lymphocytes expressing CD19, CD20dim and aberrantly…”
Get full text
Journal Article -
19
New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
Published in Italian journal of pediatrics (22-09-2011)“…Leukaemia immunotherapy represents a fascinating and promising field of translational research, particularly as an integrative approach of bone marrow…”
Get full text
Journal Article